81 related articles for article (PubMed ID: 17213801)
1. A gene transcription signature of the Akt/mTOR pathway in clinical breast tumors.
Creighton CJ
Oncogene; 2007 Jul; 26(32):4648-55. PubMed ID: 17213801
[TBL] [Abstract][Full Text] [Related]
2. AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway.
Liu LZ; Zhou XD; Qian G; Shi X; Fang J; Jiang BH
Cancer Res; 2007 Jul; 67(13):6325-32. PubMed ID: 17616691
[TBL] [Abstract][Full Text] [Related]
3. Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy.
Faried LS; Faried A; Kanuma T; Aoki H; Sano T; Nakazato T; Tamura T; Kuwano H; Minegishi T
Mol Carcinog; 2008 Jun; 47(6):446-57. PubMed ID: 18058806
[TBL] [Abstract][Full Text] [Related]
4. mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels.
Ghayad SE; Bieche I; Vendrell JA; Keime C; Lidereau R; Dumontet C; Cohen PA
Cancer Sci; 2008 Oct; 99(10):1992-2003. PubMed ID: 19016759
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer.
Generali D; Fox SB; Brizzi MP; Allevi G; Bonardi S; Aguggini S; Milani M; Bersiga A; Campo L; Dionisio R; Vergoni F; Giardini R; Dogliotti L; Bottini A; Harris AL; Berruti A
Clin Cancer Res; 2008 May; 14(9):2673-80. PubMed ID: 18451231
[TBL] [Abstract][Full Text] [Related]
6. The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis.
Yoshioka A; Miyata H; Doki Y; Yasuda T; Yamasaki M; Motoori M; Okada K; Matsuyama J; Makari Y; Sohma I; Takiguchi S; Fujiwara Y; Monden M
Oncol Rep; 2008 May; 19(5):1099-107. PubMed ID: 18425364
[TBL] [Abstract][Full Text] [Related]
7. Microarray analyses of the effects of NF-kappaB or PI3K pathway inhibitors on the LPS-induced gene expression profile in RAW264.7 cells: synergistic effects of rapamycin on LPS-induced MMP9-overexpression.
Mendes Sdos S; Candi A; Vansteenbrugge M; Pignon MR; Bult H; Boudjeltia KZ; Munaut C; Raes M
Cell Signal; 2009 Jul; 21(7):1109-22. PubMed ID: 19285553
[TBL] [Abstract][Full Text] [Related]
8. Targeting AKT signaling sensitizes cancer to cellular immunotherapy.
Hähnel PS; Thaler S; Antunes E; Huber C; Theobald M; Schuler M
Cancer Res; 2008 May; 68(10):3899-906. PubMed ID: 18483275
[TBL] [Abstract][Full Text] [Related]
9. Critical and diverse involvement of Akt/mammalian target of rapamycin signaling in human lung carcinomas.
Dobashi Y; Suzuki S; Matsubara H; Kimura M; Endo S; Ooi A
Cancer; 2009 Jan; 115(1):107-18. PubMed ID: 19090006
[TBL] [Abstract][Full Text] [Related]
10. Activation of mTOR in a subgroup of ovarian carcinomas: correlation with p-eIF-4E and prognosis.
Noske A; Lindenberg JL; Darb-Esfahani S; Weichert W; Buckendahl AC; Röske A; Sehouli J; Dietel M; Denkert C
Oncol Rep; 2008 Dec; 20(6):1409-17. PubMed ID: 19020722
[TBL] [Abstract][Full Text] [Related]
11. Regulation of mammalian target of rapamycin activity in PTEN-inactive prostate cancer cells by I kappa B kinase alpha.
Dan HC; Adli M; Baldwin AS
Cancer Res; 2007 Jul; 67(13):6263-9. PubMed ID: 17616684
[TBL] [Abstract][Full Text] [Related]
12. Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.
Kim KK; Lee JJ; Yang Y; You KH; Lee JH
Carcinogenesis; 2008 Apr; 29(4):704-12. PubMed ID: 18258606
[TBL] [Abstract][Full Text] [Related]
13. Integrated gene expression profile predicts prognosis of breast cancer patients.
Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
[TBL] [Abstract][Full Text] [Related]
14. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
[TBL] [Abstract][Full Text] [Related]
15. Expression of EBV latent antigens, mammalian target of rapamycin, and tumor suppression genes in EBV-positive smooth muscle tumors: clinical and therapeutic implications.
Ong KW; Teo M; Lee V; Ong D; Lee A; Tan CS; Vathsala A; Toh HC
Clin Cancer Res; 2009 Sep; 15(17):5350-8. PubMed ID: 19706821
[TBL] [Abstract][Full Text] [Related]
16. The biology behind mTOR inhibition in sarcoma.
Wan X; Helman LJ
Oncologist; 2007 Aug; 12(8):1007-18. PubMed ID: 17766661
[TBL] [Abstract][Full Text] [Related]
17. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
Choi UJ; Jee BK; Lim Y; Lee KH
Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
[TBL] [Abstract][Full Text] [Related]
18. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers.
Carter SL; Eklund AC; Kohane IS; Harris LN; Szallasi Z
Nat Genet; 2006 Sep; 38(9):1043-8. PubMed ID: 16921376
[TBL] [Abstract][Full Text] [Related]
19. Aerosol delivery of Akt controls protein translation in the lungs of dual luciferase reporter mice.
Tehrani AM; Hwang SK; Kim TH; Cho CS; Hua J; Nah WS; Kwon JT; Kim JS; Chang SH; Yu KN; Park SJ; Bhandari DR; Lee KH; An GH; Beck GR; Cho MH
Gene Ther; 2007 Mar; 14(5):451-8. PubMed ID: 17051249
[TBL] [Abstract][Full Text] [Related]
20. AKT1 Transcriptomic Landscape in Breast Cancer Cells.
George B; Gui B; Raguraman R; Paul AM; Nakshatri H; Pillai MR; Kumar R
Cells; 2022 Jul; 11(15):. PubMed ID: 35892586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]